Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4 Kuchena >98.0% (HPLC) Lenvatinib Mesylate Intermediate Factory
Ruifu Chemical Supply Lenvatinib Mesylate Inopindirana Nekuchena Kwakanyanya
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Chemical Name | Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate |
Mashoko anoreva zvakafanana | Lenvatinib Kusachena 47;4-Chloro-7-Methoxyquinoline-6-Carboxylic Acid Methyl Ester;4-Chloro-7-Methoxy-6-Quinolinecarboxylic Acid Methyl Ester;Lenvaint-D |
Nhamba yeCAS | 205448-66-4 |
Nhamba yeCAT | RF-PI1970 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C12H10ClNO3 |
Molecular Weight | 251.67 |
Boiling Point | 377.4±37.0℃ |
Density | 1.320±0.06 g/cm3 |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Off-White kusvika Yellow Solid Powder |
1 H NMR Spectrum | Zvinoenderana Nechimiro |
Kuchena / Analysis Method | >98.0% (HPLC) |
Kurasika paKuomesa | <1.00% |
Zvose Zvisina Kuchena | <2.00% |
Test Standard | Enterprise Standard |
Usage | Pakati/Kusachena kweLenvatinib Mesylate (CAS: 857890-39-2) |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate (CAS: 205448-66-4) iri pakati peLenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib imishonga yekenza yekenza yakagadzirwa neEisai Corporation yeJapan (Code: E7080), iri ye inhibitor ye oral multi-receptor tyrosine kinase (RTK) uye inogona kudzivisa kinase chiitiko chevascular endothelial growth factor Receptors R1 (FLT1), VEG-FR2 (KDR), R3 (FLT4).Lenvatinib inogonawo kudzivisa kubatanidzwa kwemamwe maRTK mu pathological angiogenesis, tumor kukura, uye kukura kwekenza kunze kwemaitiro avo emagetsi emagetsi anosanganisira fibroblast growth factor (FGF) receptors FGFR1, 2, 3, uye 4;platelet-derived growth factor receptor (PDGFR [alpha]), KIT, uye RET.[Zviratidzo]: Lenvatinib inokodzera kurapwa kwevarwere vekenza yethyroid yemunharaunda kudzoka kana metastasis rudzi, progressivity rudzi uye radioactive iodine-refractory differentiated type.